-
2024-519971-25-00
5
2025-12-03
Advanced MET exon 14 Mutated Non-Small Cell Lung Cancer
-
2024-510941-32-00
5
2025-12-02
Adult patients discharged alive from ICU with a decreased eGFR, and/or
-
2025-521391-58-00
4
2025-11-28
Asthma
-
2024-516625-31-00
3
2025-11-25
Advanced Solid Tumor
-
2024-519048-33-00
10
2025-11-25
resected pancreatic adenocarcinoma
-
2025-520927-26-00
5
2025-11-24
Metastatic Castration-resistant Prostate Cancer (mCRPC)
-
2025-521511-40-00
10
2025-11-18
metastatic non-small cell lung cancer
-
2024-517018-14-00
4
2025-11-17
Advanced non-small cell lung cancer
-
2024-520029-35-01
4
2025-11-17
ADVANCED BILIARY TRACT CARCINOMA
-
2024-514401-54-00
5
2025-11-13
Chronic Primary Immune Thrombocytopenia
-
2024-517411-73-00
6
2025-11-12
Patient with medium or high risk for pneumococcal invasive infection
-
2024-519871-24-00
10
2025-11-11
Breast cancer
-
2024-520190-12-00
5
2025-11-10
Breast Cancer: triple negative breast cancer (TNBC) and hormone recept
-
2025-520566-22-00
5
2025-11-10
Hormone Receptor-Positive, HER2-Negative Advanced/Metastatic Breast Ca
-
2024-517316-29-00
4
2025-11-07
Unresectable stage III Non-Small Cell Lung Cancer
-
2025-522169-31-00
4
2025-10-30
Adult Patients with HER2-IHC3+ selected solid cancers (endometrial, co
-
2023-506843-40-00
5
2025-10-29
Mycobacterium xenopi pulmonary infection
-
2024-519917-72-00
5
2025-10-29
Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with C
-
2025-520694-39-00
4
2025-10-24
Metastatic or locally advanced irresectable (stage IV) gastric cancer
-
2024-514912-28-00
10
2025-10-22
Patients with hepatocellular carcinoma with high tumor burden.
-
2024-520413-53-00
5
2025-10-21
Spinocerebellar ataxia
-
2025-522656-68-00
6
2025-10-15
Metastatic breast cancers
-
2023-509728-16-00
4
2025-10-10
advanced Parkinson’s disease
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig